Delivery Order HHSN271201500023I-HHSN27100002

Award Date 2/6/17
Potential Completion Date 9/14/20
Potential Value $232K
Awardee
Opans LLC
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27713, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse awarded a Firm Fixed Price Delivery Order contract to OPANS, LLC, a for-profit limited liability company, to provide bioanalysis testing services. The contract has a potential value of $343,940.00 and was awarded under the NIH Bioanalysis Testing Services 2015-2020 contract vehicle. The contract does not have a set-aside designation. OPANS, LLC has a consistent history of...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse awarded a Firm Fixed Price Delivery Order contract to OPANS, LLC, a for-profit limited liability company, to provide bioanalysis testing services. The contract was awarded under the NIH Bioanalysis Testing Services 2015-2020 contract vehicle, with a potential value of $144,770.00 and a completion date of September 14, 2020. The contract does not have a set-aside designation....
<p>The National Institute on Drug Abuse (NIDA), a civilian agency, awarded a $30,000.00 firm fixed price purchase order contract to the District Of Columbia Behavioral Health Association (The) for the Outreach Partnership Program (OPP). The contract has an ultimate completion date of April 30, 2020 and was awarded on April 22, 2015. The contract is not associated with a larger vehicle and does not have a set-aside designation.</p>
<p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $24,900 firm fixed price purchase order contract to Pelago Bioscience AB, a for-profit limited liability company. The contract is for the development of a new assay to test compounds of interest. The period of performance runs from the award date of September 9, 2024 through September 8, 2025. This contract award does not have a set-aside designation.</p>
The National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, awarded a $120,969.12 firm-fixed-price delivery order contract to 22nd Century Technologies, Inc., a minority-owned small business. The contract is part of the Scientific, Operations, and Administrative Resources (SOAR) multiple-award indefinite-delivery/indefinite-quantity (IDIQ) contract valued at $3.6 billion, which provides a wide range of information technology products,...
The National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health (NIH), awarded a $232,924.56 firm fixed-price delivery order contract to Gap Solutions, Inc. This contract falls under the SOAR (Scientific, Operations, and Administrative Resources to the National Institutes of Health) IDIQ vehicle. The contract is for a range of support services, including administrative, research, software development, data analytics, and clinical services, to assist NIDA...
<p>The National Institute on Drug Abuse (NIDA), a civilian agency, awarded a $24,999.10 firm fixed-price purchase order to Vizioli Omics to complete research and analysis leading to the submission of manuscripts for publication. The contract, which does not have a set-aside designation, has a period of performance through June 24, 2025. This award appears to be for a standalone project and is not associated with a larger contract vehicle.</p>
This is a $156,000.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Oncolead GMBH &amp; CO. KG, a for-profit limited liability company located in Germany. The contract does not have a set-aside designation and was awarded on September 23, 2015 with a period of performance ending on September 30, 2016. As NIDA is the agency responsible for advancing research on drug use and addiction, this contract is likely supporting the...
The National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, awarded a firm fixed-price purchase order contract to Med Associates, Inc., a for-profit, woman-owned manufacturer of behavioral research equipment. The $80,309.73 contract is for the delivery of specialized laboratory apparatus, operant conditioning systems, data analysis software, and other scientific instruments to support animal research on substance use disorders and...
The National Institute on Drug Abuse (NIDA), a civilian agency, has awarded a Delivery Order contract valued at $400,663.32 to Guidehouse Digital LLC, a for-profit limited liability company. This contract is a task order under the $3.6 billion Scientific, Operations, and Administrative Resources (SOAR) indefinite delivery vehicle (IDV) at NIDA. The contract will provide scientific, operations, and administrative support services to NIDA from July 2021 through June 2026. The contract does not...

The National Institute on Drug Abuse (NIDA), a civilian agency under the U.S. Department of Health and Human Services, awarded a $231,650.00 firm fixed-price delivery order contract to OPANS, LLC, a for-profit limited liability company, for high throughput chemical analysis services. The contract is under the NIH Bioanalysis Testing Services 2015-2020 indefinite delivery, indefinite quantity (IDIQ) vehicle. The contract has no set-aside designation and was awarded on February 6, 2017, with a final completion date of September 14, 2020. OPANS, LLC has consistently provided bioanalysis testing services to NIDA under this IDIQ contract, indicating a strong relationship and high satisfaction with the contractor's performance.

Generated 4/1/25, 6:07 PM